Comply with the latest international and domestic standards, and cooperate with the pharmacovigilance system to improve the efficiency of pharmacovigilance work
Provides solutions for drug safety in the clinical trial phase, and supports the electronic direct reporting CDE center
Have international/domestic senior pharmacovigilance experts to help enterprises quickly establish a pharmacovigilance system
Assist customers in developing and hosting call centers, WeChat, app, websites and other channels to collect drug adverse events
Service personnel with many years of clinical and pharmacovigilance experience can conduct medical coding, medical examination and other case processing services.
Assist in writing FDAAR, DSUR, PSUR and other drug warning reports
Artificial intelligence assists with signal detection and assists customers in developing risk management plans, risk minimization measures, etc.
We can help pharmaceuticals transforming past paper data to electronic, structured and standardized data.
Pharmacovigilance doctor with extensive clinical experience provides professional medical review services for pharmaceutical companies
济民可信的存在价值，就是以济世之心，行惠民之举；诚信为品，造福天下。
江西济民可信集团有限公司创建于1999年，制药历史可追溯至上世纪五十年代，现有员工12000余名，总部位于中国南昌，在江西、北京、上海、江苏、浙江多地设有产业平台和研发机构。2017年，集团营业收入突破237亿元，跻身中国制药工业100强第6位、中国医药工业100强第10位。
秉承创新驱动的战略方针，公司专注于现代中药、化学药、生物制剂、保健品的研发、生产和销售，拥有7家制药基地、1座国际级博士后工作站、1个获CNAS认证的国家级实验室、5个省级工程技术中心，并在海外设立新药研发团队。当前，集团在心脑血管科、肾科、肿瘤科、抗感染及急救药物领域取得丰硕成果，核心产品“金水宝”、“醒脑静”、“康莱特”、“悉能”、“立幸”、“黄氏响声丸”、“九华痔疮栓”等在全国细分品类拥有较高市场份额。
Add to Favorites
